These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1164085)

  • 1. Cooperativity in classical receptor theory.
    Scaf AH
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):4-12. PubMed ID: 1164085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor theories and quantitative effect versus dose-concentration relationship.
    Tallarida RJ
    Drug Metab Rev; 1984; 15(1-2):345-63. PubMed ID: 6745084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
    Pennefather P; Quastel DM
    Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors.
    Järv J
    J Theor Biol; 1995 Aug; 175(4):577-82. PubMed ID: 7475093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation.
    Vauquelin G; Szczuka A
    Neurochem Int; 2007 Oct; 51(5):254-60. PubMed ID: 17606314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S; Sallés J
    Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.
    Langmead CJ
    J Biomol Screen; 2007 Aug; 12(5):668-76. PubMed ID: 17478477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convection, diffusion and reaction in a surface-based biosensor: modeling of cooperativity and binding site competition on the surface and in the hydrogel.
    Lebedev K; Mafé S; Stroeve P
    J Colloid Interface Sci; 2006 Apr; 296(2):527-37. PubMed ID: 16359694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
    Figler H; Olsson RA; Linden J
    Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation.
    Hafner D; Heinen E; Noack E
    Arzneimittelforschung; 1977; 27(10):1871-3. PubMed ID: 579093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor theory.
    Kenakin T
    Curr Protoc Pharmacol; 2008 Jun; Chapter 1():Unit1.2. PubMed ID: 22294216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
    Heitman LH; Ye K; Oosterom J; Ijzerman AP
    Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of drug-receptor affinity measures in the differentiation of receptors.
    Tallarida RJ
    Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the potency and molecular mechanism of action of insurmountable antagonists.
    Kenakin T; Jenkinson S; Watson C
    J Pharmacol Exp Ther; 2006 Nov; 319(2):710-23. PubMed ID: 16857731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the analysis of pharmacological experiments in terms of an allosteric receptor model.
    Thron CD
    Mol Pharmacol; 1973 Jan; 9(1):1-9. PubMed ID: 4685448
    [No Abstract]   [Full Text] [Related]  

  • 19. Allosteric interactions between the binding sites of receptor agonists and guanine nucleotides: a comparative study of the 5-hydroxytryptamine1A and adenosine A1 receptor systems in rat hippocampal membranes.
    Mahle CD; Wiener HL; Yocca FD; Maayani S
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1275-84. PubMed ID: 1469633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA; Miller RC; Eck M; Paquet JL
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.